Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Decreases By 94.0%

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 6,400 shares, a decrease of 94.0% from the January 15th total of 106,400 shares. Based on an average daily trading volume, of 317,300 shares, the days-to-cover ratio is currently 0.0 days.

CV Sciences Stock Performance

Shares of OTCMKTS:CVSI traded down $0.00 during trading on Wednesday, reaching $0.04. 348,179 shares of the stock traded hands, compared to its average volume of 221,746. The stock has a 50-day moving average of $0.04 and a two-hundred day moving average of $0.04. CV Sciences has a 52-week low of $0.03 and a 52-week high of $0.10. The stock has a market cap of $7.85 million, a P/E ratio of -4.25 and a beta of 0.69.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.